BriaCell Therapeutics(BCTXZ)

WEST VANCOUVER, British Columbia, Canada

Biotechnology

Focus: Immunotherapies

BriaCell Therapeutics is a life sciences company focused on Immunotherapies.

Oncology

Funding Stage

PUBLIC

Open Jobs

Pipeline & Clinical Trials

SV-BR-1-GM

Phase 1/2

Clinical Trials (1)

NCT03328026Combination Study of SV-BR-1-GM With Retifanlimab

Phase 1/2

SV-BR-1-GM

Phase 1/2

Clinical Trials (1)

NCT03066947SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

Phase 1/2

BC1 cell line

Phase 1/2

Clinical Trials (1)

NCT06471673A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Phase 1/2

SV-BR-1-GM

Phase 3

Clinical Trials (1)

NCT06072612Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Phase 3

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 4 clinical trials

SEC Filings: 2 available

R&D Spend

$27M77%

Net Income

-$5M

Cash

$862K